• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外诊断医疗器械非选择性差异的量化

Quantification of Difference in Nonselectivity Between In Vitro Diagnostic Medical Devices.

作者信息

Fauskanger Pernille Kjeilen, Sandberg Sverre, Johansen Jesper, Keller Thomas, Budd Jeffrey, Miller W Greg, Stavelin Anne, Delatour Vincent, Panteghini Mauro, Støve Bård

机构信息

Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.

Department of Mathematics, University of Bergen, Bergen, Norway.

出版信息

Biom J. 2025 Feb;67(1):e70032. doi: 10.1002/bimj.70032.

DOI:10.1002/bimj.70032
PMID:39748445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695778/
Abstract

Correct measurement results from in vitro diagnostic (IVD) medical devices (MD) are crucial for optimal patient care. The performance of IVD-MDs is often assessed through method comparison studies. Such studies can be compromised by the influence of various factors. The effect of these factors must be examined in every method comparison study, for example, nonselectivity differences between compared IVD-MDs are examined. Historically, selectivity or nonselectivity has been defined as a qualitative term. However, a quantification of nonselectivity differences between IVD-MDs is needed. This paper fills this need by introducing a novel measure for quantifying differences in nonselectivity (DINS) between a pair of IVD-MDs. Assuming one of the IVD-MDs involved in the comparison exhibits high selectivity for the analyte, it becomes feasible to quantify nonselectivity in the other IVD-MD by employing this DINS measure. Our approach leverages elements from univariate ordinary least squares regression and incorporates repeatability IVD-MD variances, resulting in a normalized measure. We also introduce a plug-in estimator for this measure, which is notably linked to the average relative increase in prediction interval widths attributable to DINS. This connection is exploited to establish a criterion for identifying excessive DINS utilizing a proof-of-hazard approach. Utilizing Monte Carlo simulations, we investigate how the estimator relates to population characteristics like DINS and heteroskedasticity. We find that DINS impacts the mean, variance, and 99th percentile of the estimator, while heteroskedasticity affects only the latter two, and to a considerably smaller extent compared to DINS. Importantly, the size of the study design modulates these effects. We also confirm, when using clinical data, that DINS between pairs of IVD-MDs influence the estimator correspondingly to those of simulated data. Thus, the proposed estimator serves as an effective metric for quantifying DINS between IVD-MDs and helping to determine the quality of a method comparison study.

摘要

体外诊断(IVD)医疗器械(MD)的正确测量结果对于实现最佳患者护理至关重要。IVD-MD的性能通常通过方法比较研究来评估。此类研究可能会受到各种因素的影响。在每项方法比较研究中都必须检查这些因素的影响,例如,检查所比较的IVD-MD之间的非选择性差异。从历史上看,选择性或非选择性一直被定义为一个定性术语。然而,需要对IVD-MD之间的非选择性差异进行量化。本文通过引入一种新颖的度量来满足这一需求,该度量用于量化一对IVD-MD之间的非选择性差异(DINS)。假设参与比较的IVD-MD之一对分析物具有高选择性,那么通过采用这种DINS度量来量化另一个IVD-MD中的非选择性就变得可行。我们的方法利用了单变量普通最小二乘回归的元素,并纳入了IVD-MD的重复性方差,从而得到一个标准化的度量。我们还为该度量引入了一个插件估计器,该估计器特别与归因于DINS的预测区间宽度的平均相对增加相关联。利用这种联系,通过风险证明方法建立了一个识别过度DINS的标准。利用蒙特卡罗模拟,我们研究了估计器与DINS和异方差等总体特征之间的关系。我们发现DINS会影响估计器的均值、方差和第99百分位数,而异方差仅影响后两者,并且与DINS相比影响程度要小得多。重要的是,研究设计的规模会调节这些影响。我们还通过临床数据证实,IVD-MD对之间的DINS对估计器的影响与模拟数据的影响相对应。因此,所提出的估计器是量化IVD-MD之间DINS并有助于确定方法比较研究质量的有效指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/766cfbe5f23e/BIMJ-67-e70032-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/26d71bc0acf1/BIMJ-67-e70032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/a260d802d027/BIMJ-67-e70032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/526c75024c26/BIMJ-67-e70032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/f48a55f62adb/BIMJ-67-e70032-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/120aa70bb928/BIMJ-67-e70032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/1fea6aeee1d0/BIMJ-67-e70032-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/c196dd755aa3/BIMJ-67-e70032-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/766cfbe5f23e/BIMJ-67-e70032-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/26d71bc0acf1/BIMJ-67-e70032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/a260d802d027/BIMJ-67-e70032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/526c75024c26/BIMJ-67-e70032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/f48a55f62adb/BIMJ-67-e70032-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/120aa70bb928/BIMJ-67-e70032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/1fea6aeee1d0/BIMJ-67-e70032-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/c196dd755aa3/BIMJ-67-e70032-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1b/11695778/766cfbe5f23e/BIMJ-67-e70032-g007.jpg

相似文献

1
Quantification of Difference in Nonselectivity Between In Vitro Diagnostic Medical Devices.体外诊断医疗器械非选择性差异的量化
Biom J. 2025 Feb;67(1):e70032. doi: 10.1002/bimj.70032.
2
Recommendations for Setting a Criterion and Assessing Commutability of Sample Materials Used in External Quality Assessment/Proficiency Testing Schemes.用于外部质量评估/能力验证计划中样品材料的定标和可替代性评估的建议。
Clin Chem. 2023 Nov 2;69(11):1227-1237. doi: 10.1093/clinchem/hvad135.
3
A Monte Carlo evaluation of five interval estimators for the relative risk in sparse data.稀疏数据中相对风险的五种区间估计量的蒙特卡罗评估。
Biom J. 2006 Feb;48(1):131-43. doi: 10.1002/bimj.200410193.
4
Clinical evidence requirements according to the IVDR 2017/746: practical tools and references for underpinning clinical evidence of IVD-MDs.根据 2017/746 IVDR 的临床证据要求:为支持体外诊断医疗器械(IVD-MDs)的临床证据提供实用工具和参考。
Clin Chem Lab Med. 2023 Mar 15;61(7):1150-1157. doi: 10.1515/cclm-2022-1252. Print 2023 Jun 27.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
7
A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.简单交叉设计下相对治疗效果的点估计和区间估计的说明。
Pharm Stat. 2022 Mar;21(2):386-394. doi: 10.1002/pst.2176. Epub 2021 Nov 9.
8
Interval estimation of the mean difference in the analysis of over-dispersed count data.过度离散计数数据分析中平均差的区间估计。
Biom J. 2013 Jan;55(1):114-33. doi: 10.1002/bimj.201200032. Epub 2012 Dec 6.
9
[Safety of high risk in vitro diagnostic medical devices : international and national measures].[高风险体外诊断医疗器械的安全性:国际和国家措施]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Jun;52(6):610-8. doi: 10.1007/s00103-009-0852-2.
10
Monte Carlo methods for nonparametric regression with heteroscedastic measurement error.具有异方差测量误差的非参数回归的蒙特卡罗方法。
Biometrics. 2018 Jun;74(2):498-505. doi: 10.1111/biom.12765. Epub 2017 Sep 15.

引用本文的文献

1
Recommendations for assessing commutability of a replacement batch of a secondary calibrator certified reference material.关于评估二级校准物认证参考物质替代批次互换性的建议。
Clin Chim Acta. 2025 Feb 1;567:120097. doi: 10.1016/j.cca.2024.120097. Epub 2024 Dec 16.

本文引用的文献

1
Recommendations for Setting a Criterion and Assessing Commutability of Sample Materials Used in External Quality Assessment/Proficiency Testing Schemes.用于外部质量评估/能力验证计划中样品材料的定标和可替代性评估的建议。
Clin Chem. 2023 Nov 2;69(11):1227-1237. doi: 10.1093/clinchem/hvad135.
2
Documenting and validating metrological traceability of serum alanine aminotransferase measurements: a priority for medical laboratory community for providing high quality service in hepatology.记录和验证血清丙氨酸氨基转移酶测量的计量溯源性:医学检验界在肝病学中提供高质量服务的优先事项。
Clin Chem Lab Med. 2023 Sep 13;62(2):249-252. doi: 10.1515/cclm-2023-0900. Print 2024 Jan 26.
3
Recommendations for Setting a Criterion for Assessing Commutability of Secondary Calibrator Certified Reference Materials.
关于设定评估二级校准物有证标准物质互换性标准的建议。
Clin Chem. 2023 Sep 1;69(9):966-975. doi: 10.1093/clinchem/hvad104.
4
IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples.IFCC 工作组关于评估可比性的建议 第 2 部分:使用参考物质和临床样本之间的偏倚差异。
Clin Chem. 2018 Mar;64(3):455-464. doi: 10.1373/clinchem.2017.277541. Epub 2018 Jan 18.
5
IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material.IFCC 工作组关于评估等效性的建议 第 3 部分:使用参考物质的校准有效性。
Clin Chem. 2018 Mar;64(3):465-474. doi: 10.1373/clinchem.2017.277558. Epub 2018 Jan 18.
6
IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design.国际临床化学联合会工作组关于评估可比性的建议 第 1 部分:一般实验设计。
Clin Chem. 2018 Mar;64(3):447-454. doi: 10.1373/clinchem.2017.277525. Epub 2018 Jan 18.
7
American Liver Guidelines and Cutoffs for "Normal" ALT: A Potential for Overdiagnosis.美国肝脏指南及“正常”谷丙转氨酶的临界值:存在过度诊断的可能性。
Clin Chem. 2017 Jul;63(7):1196-1198. doi: 10.1373/clinchem.2017.274977. Epub 2017 May 17.
8
Validation and verification of measurement methods in clinical chemistry.临床化学中测量方法的验证与确认
Bioanalysis. 2012 Feb;4(3):305-20. doi: 10.4155/bio.11.311.
9
A unified approach for nonparametric evaluation of agreement in method comparison studies.方法比较研究中一致性非参数评估的统一方法。
Int J Biostat. 2010;6(1):Article 19. doi: 10.2202/1557-4679.1235.
10
Total deviation index for measuring individual agreement with applications in laboratory performance and bioequivalence.用于衡量个体一致性的总偏差指数及其在实验室性能和生物等效性中的应用。
Stat Med. 2000 Jan 30;19(2):255-70. doi: 10.1002/(sici)1097-0258(20000130)19:2<255::aid-sim293>3.0.co;2-8.